BioEclipse Therapeutics rakes in $7.7 mln
South San Francisco-based BioEclipse Therapeutics, a clinical-stage biopharmaceutical company, has raised $7.7 million in Series A-1 financing. Revelis Capital Group LLC led the round.
24 June 2019•1 min read
